Abraxis BioScience, Inc. today announced that ABRAXANE powder for suspension for infusion (an albumin-bound nanoparticle formulation of paclitaxel), has received a positive opinion in favor of approval from the European Committee for Human Medicinal Products for the treatment of metastatic breast cancer in women who have failed therapy in the first-line setting.
Ultratech, Inc. today announced unaudited results for the three-month and nine-month periods ended September 29, 2007. The company's net loss for the third quarter of 2007 was $0.9 million or $0.04 per share on net sales of $25.2 million.
VeruTEK Technologies, Inc. announced the completion of a private placement offering whereby the Company sold approximately 1.34 million shares of its common stock plus warrants to purchase approximately 2.7 million additional shares of common stock.
JPK Instruments AG, the market leader in BioSPM, is the No. 1 and hence the fastest growing company of the nanotech industry on the Deloitte Technology Fast 50 ranking, which has been established for the fifth consecutive year.
Nanosys, Inc. today announced the expansion and extension of its collaborative agreement with Sharp Corporation, of Osaka, Japan, to develop nanotechnology enabled fuel cells incorporating Nanosys' proprietary nanostructure technology.
This Frost & Sullivan research service titled Arsenic Contamination of Drinking Water - A Global Perspective provides an overview of the current global crisis, including an analysis of the regulatory compliance issues, an assessment of emerging technologies, and a discussion of prevailing market forces and opportunities.
The Society of Manufacturing Engineers announced that Dr. Michael T. Postek, chief of the precision engineering division at the National Institute of Standards and Technology has been confirmed as the keynote speaker for both the MicroManufacturing and NanoManufacturing Conferences.